Yan Huang - Publications

Affiliations: 
Seoul National University, Seoul, South Korea 

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Jeon B, Kim MO, Kim YS, Han HY, Yun JH, Kim J, Huang Y, Choi Y, Cho CH, Kang BC, Kim S, Choi TH. Optimization and validation of a method to identify skin sensitization hazards using IL-1 α and IL-6 secretion from HaCaT. Toxicology in Vitro : An International Journal Published in Association With Bibra. 104589. PMID 31276782 DOI: 10.1016/j.tiv.2019.104589  0.68
2019 Kang S, Park GH, Kim S, Kim J, Choi Y, Huang Y, Lee Y, Choi TH. In Vitro and In Vivo Antimicrobial Activity of Antibiotic-Conjugated Carriers with Rapid pH-Responsive Release Kinetics. Advanced Healthcare Materials. e1900247. PMID 31081217 DOI: 10.1002/adhm.201900247  0.68
2019 Jeon B, Jeong B, Jee S, Huang Y, Kim Y, Park GH, Kim J, Wufuer M, Jin X, Kim SW, Choi TH. A Facial Recognition Mobile App for Patient Safety and Biometric Identification: Design, Development, and Validation. Jmir Mhealth and Uhealth. 7: e11472. PMID 30958275 DOI: 10.2196/11472  0.68
2016 Hong S, Chen N, Fang W, Zhan J, Liu Q, Kang S, He X, Liu L, Zhou T, Huang J, Chen Y, Qin T, Zhang Y, Ma Y, Yang Y, ... ... Huang Y, et al. Upregulation of PD-L1 by EML4-ALK fusion protein mediates the immune escape in ALK positive NSCLC: Implication for optional anti-PD-1/PD-L1 immune therapy for ALK-TKIs sensitive and resistant NSCLC patients. Oncoimmunology. 5: e1094598. PMID 27141355 DOI: 10.1080/2162402X.2015.1094598  0.68
2016 Zhang Y, Sheng J, Yang Y, Fang W, Kang S, He Y, Hong S, Zhan J, Zhao Y, Xue C, Ma Y, Zhou T, Ma S, Gao F, Qin T, ... ... Huang Y, et al. Optimized selection of three major EGFR-TKIs in advanced EGFR-positive non-small cell lung cancer: a network metaanalysis. Oncotarget. PMID 26933807 DOI: 10.18632/oncotarget.7713  0.68
Show low-probability matches.